[ad_1]
Subscribe to receive the most important news
The Ministry of Health has denied the lack of contraceptive drugs in family planning clinics, health units and mobile clinics, of which 60% of women benefit from their needs and receive 98% subsidized prices and free in the zones. remote and poor.
Dr. Sahar El-Sonbaty, head of the family planning and reproductive health sector, told Al-Masry Al-Youm that the ministry was receiving contraceptive drugs from local and government businesses. In pharmacies, it should be noted that what is said about the shortage is expensive imported species that are sold in pharmacies and used by about 40% of women of childbearing age.
Al-Sonbati denied rumors that contraceptive drugs distributed by the ministry would be at the origin of cancerous tumors, pointing out that these methods were protecting women from ovarian cancer and that they were not were not administered solely on medical advice.
In the same context, said Dr. Ali Auf, head of the General Division of Medicines of the Federation of Chambers of Commerce, there has been a breakthrough in the shortage of contraceptive drugs seen by pharmacies in the last days after the intensification of control campaigns and inspection of distributors at the origin of this crisis. Nearly 30% of the gaps in pharmacies and in the next 3 weeks will end the crisis.
Auf told Al-Masry Al-Youm that the crisis was due to poor distribution, the storage of some distributors and the resale of drugs on the black market, stating that these drugs were available in health protection centers. childhood and motherhood.
He pointed out that pharmacies still suffer from a significant shortage of essential and strategic drugs, such as heart medications, sugar, pressure and some oncology drugs, including tablets' Riparil 40 milligrams' for the treatment of vascular dysfunction and 'streptokinis' to dissolve heart clots, one of the most urgent drugs. And the drug "Adancor 10 milligrams", tablet for angina, in addition to the drugs used in the treatment of stroke and ephedrine ampoules for the treatment of heart attacks and other, and other alternative medicines are used for the patient because of the monopoly practices of pharmaceutical companies and the intervention of the Ministry to resolve the crisis. Some companies market the species to increase their prices.
[ad_2]
Source link
